SCN1A is the most clinically relevant gene in a wide spectrum of epilepsy phenotypes ranging from febrile seizures to Dravet syndrome (DS) (Aljaafari et al., 2017). This evidence concerns the gene SCN1A and Febrile seizure (within the age range of 3 months to 6 years).